Search

Search Constraints

You searched for: Author/Creator Harding, James J.

Search Results

1. A phase 1/1B trial of ADI‐PEG 20 plus nab‐paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma. Issue 23 (18th August 2017)

2. A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases. (8th May 2015)

3. A Retrospective Evaluation of Vemurafenib as Treatment for BRAF‐Mutant Melanoma Brain Metastases. (8th May 2015)

4. Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study. Issue 24 (20th August 2021)

5. Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment. (25th February 2022)

6. Clinical activity of ipilimumab for metastatic uveal melanoma. Issue 20 (2nd August 2013)

7. Clinical activity of ipilimumab for metastatic uveal melanoma: A retrospective review of the Dana‐Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan‐Kettering Cancer Center, and University Hospital of Lausanne experience. Issue 20 (2nd August 2013)

8. Clinical implications of drug‐induced liver injury in early‐phase oncology clinical trials. Issue 22 (18th August 2020)

9. Embolization with microspheres alone for hepatocellular carcinoma with portal vein tumor: analysis of outcome and liver function at disease progression. Issue 4 (April 2020)

10. Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution. Issue 11 (November 2019)